16D0 Mago, Rajnish - Thomas Jefferson University - Thomas Jefferson University
rxm256

Rajnish Mago, MD

Contact Dr. Mago

833 Chestnut East, Suite 210
Philadelphia, PA 19107

(215) 955-9474
(215) 503-5698 fax

Most Recent Peer-reviewed Publications

  1. Levomilnacipran: A newly approved drug for treatment of major depressive disorder
  2. Cardiovascular adverse effects of newer antidepressants
  3. 6 'd's: Next steps after an insufficient antipsychotic response
  4. Erratum: Safety and tolerability of levomilnacipran ER in major depressive disorder: Results from an open-label, 48-Week extension study(Clin Drug Investig (2013):33:761-771 DOI 10.1007/s40261-013-0126-5)
  5. Safety and tolerability of levomilnacipran ER in major depressive disorder: Results from an open-label, 48-week extension study
  6. Antidepressant-induced excessive sweating: Clinical features and treatment with terazosin
  7. Antidepressant-induced excessive sweating: Clinical features and treatment with terazosin
  8. Glycopyrrolate for antidepressant-associated excessive sweating
  9. Lamotrigine for major depressive disorder is inappropriate
  10. Identifying potential adverse effects by patients' ratings: A proof-of-concept study of a novel approach
  11. Antidepressants and the risk of abnormal bleeding during spinal surgery: A case-control study
  12. Reducing CYP450 drug interactions caused by antidepressants
  13. Antidepressants and persistent pulmonary hypertension of the newborn
  14. Efficacy of drugs in bipolar depression: What the data show
  15. Practical implications of a study on treating chronic insomnia
  16. Proposed strategies for successful clinical management with aripiprazole
  17. Medically serious adverse effects of newer antidepressants
  18. Urinary retention associated with ziprasidone: A case report
  19. Antiadrenergic treatment of antidepressant-induced excessive sweating in 3 patients [6]
  20. An open-label, rater-blinded, augmentation study of aripiprazole in treatment-resistant depression
0